Scientists have found a biomarker that can predict the severe form of COVID-19
The number of killer T cells in a patient's blood can be a biomarker that can predict the severity of the course of coronavirus infection, even at an early stage of the disease. This is reported by RIA Novosti, citing a study by an international team of scientists led by Professor Burkhard Becher from the Institute of Experimental Immunology at the University of Zurich.
As specified, these cells are part of the early immune response.
The researchers believe that the new biomarker test will help doctors make quick decisions about the type of treatment, as well as transfer patients to the intensive care unit on time.
According to Becher, the immune responses to the various pneumonias are very similar, but in the case of coronavirus infection, T cells and natural killer cells “exhibit unique behaviors.”
Earlier it was reported that scientists have identified a link between body weight and the risk of complications from COVID-19.
It also became known why people with the second blood group have an increased risk of contracting coronavirus.